<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336255">
  <stage>Registered</stage>
  <submitdate>18/11/2010</submitdate>
  <approvaldate>22/11/2010</approvaldate>
  <actrnumber>ACTRN12610001018000</actrnumber>
  <trial_identification>
    <studytitle>Misoprostol versus Oxytocin as prophylaxes against intraoperative and postoperative bleeding in cesarean section</studytitle>
    <scientifictitle>Misoprostol versus Oxytocin as prophylaxes against intraoperative and postoperative bleeding in cesarean section</scientifictitle>
    <utrn>U1111-1118-2108</utrn>
    <trialacronym />
    <secondaryid>no secondary Id</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>bleeding in cesarean section</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>600 microgram misoprostol (3 tablets) administrated rectally, right after induction of anesthesia.</interventions>
    <comparator>10 ml oxytocin infused with 500 cc ringer solution right after clamping of the cord</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Intraoperative blood loss during Elective lower segment cesarean sections</outcome>
      <timepoint>Number and weight differences of towels used intraoperatively</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>change in Hemoglobin levels pre and post operative</outcome>
      <timepoint>Measuring blood hemoglobin pre and post operative</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>patients admitted for elective lower segment cesarean section</inclusivecriteria>
    <inclusiveminage>15</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>patients with risk factors for postpartum hemorrhage, emergency lower segment cesarean section, or known hypersensitivity to prostaglandins.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelops (containers)</concealment>
    <sequence>Simple Randomization using a randomization table created by a computer software</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/12/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>220</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>Cairo</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Ain Shams University</primarysponsorname>
    <primarysponsoraddress>Ain Shams university Maternity Hospital, el demerdash Hospitals, El Abassia, Cairo, Egypt.</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Amany Sadek</fundingname>
      <fundingaddress>3/A, A.O.I buildings, Makram Ebad St., Nasr City, Cairo, Egypt</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To compare the efficacy of rectally administrated Misoprostol vs. intravenous Oxytocin infusion during and after cesarean sections to control intraoperative and postoperative bleeding.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ain Shams Maternity Hospital Ethics committee</ethicname>
      <ethicaddress>Ain Shams Maternity Hospital, Eldemerdash univeristy Hospital, El Abassia, Cairo, Egypt.</ethicaddress>
      <ethicapprovaldate>13/10/2010</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Amany Sadek</name>
      <address>3/A, A.O.I. buildings, Makram Ebad St., Nasr city, Cairo, Egypt.</address>
      <phone>020 10 65 63 603</phone>
      <fax />
      <email>amanitoo@hotmail.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Amany Sadek</name>
      <address>3/A, A.O.I. buildings, Makram Ebad St., Nasr city, Cairo, Egypt.</address>
      <phone>020 10 65 63 603</phone>
      <fax />
      <email>amanitoo@hotmail.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Amany Sadek</name>
      <address>3/A, A.O.I. buildings, Makram Ebad St., Nasr city, Cairo, Egypt.</address>
      <phone>020 10 65 63 603</phone>
      <fax />
      <email>amanitoo@hotmail.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>